Drug intelligence / Profile preview

Listerine Zero

Development stage: Phase 4
Lead developer: Johnson & Johnson Consumer Inc. (J&JCI)
Modality: Small Molecules
Administration: Oral

Overview

Listerine Zero is an alcohol-free essential oil-containing mouthrinse developed by Johnson & Johnson Consumer and Personal Products Worldwide. It is investigated for its efficacy in reducing existing gingivitis and plaque, and its potential to reduce SARS-CoV-2 viral load. The product is administered orally as a rinse or gargle.

Brand names: Listerine Zero
Other names: Listerine Zero Mouthwash (without alcohol)Listerine Zero Mouthwash Product

Beyond the preview

Go deeper on Listerine Zero.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Listerine Zero.

Explore the full profile